Cancer of long bone of lower limb
disease diseaseOn this page
Also known as cancer of hindlimb long bonehindlimb long bone cancermalignant hindlimb long bone neoplasmmalignant neoplasm of hindlimb long bone
Summary
Cancer of long bone of lower limb (MONDO:0000952) is a cancer. A subtype of cancer affecting bone of limb skeleton — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | cancer of long bone of lower limb |
| Mondo ID | MONDO:0000952 |
| DOID | DOID:10149 |
| ICD-10-CM | C40.2 |
| SNOMED CT | 449627008 |
| UMLS | C3265932 |
| MedGen | 757711 |
| GARD | 0022853 |
| Anatomy (UBERON) | UBERON:0003608 |
| Is cancer (heuristic) | yes |
Also known as: cancer of hindlimb long bone · hindlimb long bone cancer · malignant hindlimb long bone neoplasm · malignant neoplasm of hindlimb long bone
Disease family
An umbrella term covering 2 Mondo subtypes.
Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorder › musculoskeletal system cancer › bone cancer › cancer affecting bone of limb skeleton › cancer of long bone of lower limb
Related subtypes (3): cancer of short bone of lower limb, cancer of short bone of upper limb, cancer of long bone of upper limb
Subtypes (2): femoral cancer, tibial adamantinoma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.